Health Catalyst, Inc. (HCAT) Revenue 2017–2025
Health Catalyst, Inc. (HCAT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$311.1MFY2025 · since FY2017: $73.1M → $311.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $311.1M | +1.5% |
| FY2024 | $306.6M | +3.6% |
| FY2023 | $295.9M | +7.1% |
| FY2022 | $276.2M | +14.2% |
| FY2021 | $241.9M | +28.1% |
| FY2020 | $188.8M | +21.9% |
| FY2019 | $154.9M | +37.6% |
| FY2018 | $112.6M | +54.0% |
| FY2017 | $73.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HCAT financial trends
HCAT Net incomeHCAT Net marginHCAT Gross profitHCAT Gross marginHCAT Operating incomeHCAT Operating marginHCAT Operating cash flowHCAT Free cash flowHCAT Capital expendituresHCAT Return on equityHCAT Stock buybacksHCAT Dividends paidHCAT Total assetsHCAT Total liabilitiesHCAT Shareholders’ equityHCAT overview →